Fertility and Sterility
Volume 89, Issue 6 , Pages 1685-1693, June 2008

Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization–intracytoplasmic sperm injection patients

  • Peter G.A. Hompes, M.D., Ph.D.

      Affiliations

    • Vrije Universiteit Medical Centre, Amsterdam, The Netherlands
    • Corresponding Author InformationReprint requests: Peter G. A. Hompes, M.D., Ph.D., Department of Obstetrics and Gynaecology, Vrije Universiteit Medical Centre, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands (FAX: 31-20-444-00-45).
    • ,
  • Frank J. Broekmans, M.D., Ph.D.

      Affiliations

    • University Medical Centre Utrecht, Utrecht, The Netherlands
    • ,
  • Diederik A. Hoozemans, M.D.

      Affiliations

    • Vrije Universiteit Medical Centre, Amsterdam, The Netherlands
    • ,
  • Roel Schats, M.D., Ph.D.

      Affiliations

    • Vrije Universiteit Medical Centre, Amsterdam, The Netherlands
    • ,
  • FIRM group

      Affiliations

    • FIRM = First IVF-ICSI Cycle Recombinant FSH vs. Menotropin.

Received 15 March 2007; received in revised form 23 May 2007; accepted 23 May 2007. published online 07 August 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 The research institutes of the participating centers were supported by Ferring BV, Hoofddorp, The Netherlands. P.G.A.H. has conducted clinical research sponsored by Abbott, Ferring, Organon, Schering, and Serono. F.J.B. has conducted clinical research sponsored by Wyeth, Ferring, Organon, and Serono.

PII: S0015-0282(07)01207-1

doi:10.1016/j.fertnstert.2007.05.039

Fertility and Sterility
Volume 89, Issue 6 , Pages 1685-1693, June 2008

Article Tools

* Image Usage & Resolution